Drug Trial Radar · NCT07052097
Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Jul 31, 2025
Primary completion
Sep 12, 2025
Study completion Nov 28, 2025
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate TQC2938 injection in all patients receiving background treatment with azelastine fluticasone nasal spray. The efficacy, safety and immunogenicity of the injection in patients with seasonal allergic rhinitis compared with placebo are expected to include 136 patients.
Conditions
- Seasonal Allergic Rhinitis
Interventions
TQC2938 injectionDrug
TQC2938 injection is a humanized monoclonal antibody that interfering with the signal cascade.
TQC2938 PlaceboDrug
TQC2938 placebo, 4 weeks as a treatment cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retrospective nasal symptom score after 2 weeksTime frame: Baseline up to 2 weeks
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Beijing TongRen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Ganzu Province People's Hospital
Lanzhou, Ganzu, China
Cangzhou central hosipital
Cangzhou, Hebei, China
Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China
First Affiliated Hospital, Heilongjang University of Chinese Medigine
Harbin, Heilongjang, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
People'S Hospital of Zhengzhou
Zhengzhou, Henan, China
Zhengzhou Central Hospital
Zhengzhou, Henan, China
Tongji Hospital of Tongji medical college of HUST
Wuhan, Hubei, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
Northern Jiangsu People'S Hospital
Yangzhou, Jiangsu, China
The first hospital of Jilin University
Changchun, Jilin, China
China-japan Friendship Hospital, Jilin University
Changchun, Jilin, China
Affiliated Zhongshan Hospital Of Dalian university
Dalian, Liaoning, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine
Xi'an, Shaanxi, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
The Second People's Hospital of Shandong Province
Jinan, Shandong, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Zibo Central Hospital
Zibo, Shandong, China
First Hospital of Shangxi Medical University
Taiyuan, Shangxi, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Tianjin First Central Hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.